<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04365777</url>
  </required_header>
  <id_info>
    <org_study_id>ChiECRCT20200002</org_study_id>
    <nct_id>NCT04365777</nct_id>
  </id_info>
  <brief_title>SedLine for Monitoring EEG Characteristics in Neurosurgical Patients-1</brief_title>
  <official_title>SedLine for Monitoring EEG Characteristics of Different Sedation Depths in Neurosurgical Patients-1</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beijing Tiantan Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Beijing Tiantan Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Electroencephalogram (EEG) is be used to assess the depth of anesthesia.The SedLine brain
      function monitoring has four simultaneous channels of frontal EEG waveforms and helps to
      monitor the state of the brain under anesthesia with bilateral data acquisition and process
      of EEG signals. The purpose of this study is to observe and compare the EEG signatures (such
      as SEF, PSI, DSA, etc.) at various levels of sedation in neurosurgical patients administered
      with different intravenous anesthetics.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 2020</start_date>
  <completion_date type="Anticipated">May 2022</completion_date>
  <primary_completion_date type="Anticipated">May 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Spectral edge frequency 95% (SEF95) changes at different sedation depths in neurosurgical patients</measure>
    <time_frame>Prior to anesthesia induction, three minutes after reaching the target level of sedation</time_frame>
    <description>SEF95 will be measured at awake, eye-closed state and after reaching the steady-state sedation depths of OAA/S=3 and OAA/S=1.</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Electroencephalography</condition>
  <arm_group>
    <arm_group_label>Awake group</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Mild sedation group</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Deep sedation group</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>OAA/S=5</intervention_name>
    <description>Prior to anesthesia induciton, EEG signatures will be recorded at Observer's Assessment of Alertness/Sedation (OAA/S) score of 5 (awake, eye-close state) for few minutes.</description>
    <arm_group_label>Awake group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>OAA/S=3</intervention_name>
    <description>Given sedative anesthetics (propofol, midazolam or dexmetomidine), EEG signatures will be recorded after reaching steady state of OAA/S=3 (responds only after name called loudly and/or repeatedly) for few minutes.</description>
    <arm_group_label>Mild sedation group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>OAA/S=1</intervention_name>
    <description>Increasing drug concentration, EEG signatures will be recorded after reaching steady state of OAA/S=1 (does not respond to noxious stimuli) for few minutes.</description>
    <arm_group_label>Deep sedation group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The population will be selected from patients who schedule to receive elective unilateral
        frontal intracranial tumor resection in Beijing Tiantan Hospital.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients undergoing elective unilateral frontal intracranial tumor resection under
             general anesthesia;

          2. Aged 18-60 years;

          3. ASA I to II;

          4. All those who sign the informed consent form.

        Exclusion Criteria:

          1. Obese patients, BMI&gt;30kg/m2;

          2. Patients with Mallampati class III to IV airway anatomy;

          3. Combined with other neurological or psychiatric diseases;

          4. Combined with disturbance of consciousness;

          5. Previous intracranial surgery;

          6. Known or suspected cardiac dysfunction;

          7. Allergic to intravenous general anesthetics;

          8. Long-term history of analgesia, sedation and drug abuse.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Beijing Tiantan Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100050</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Beijing TianTan Hospital</name>
      <address>
        <city>Beijing</city>
        <zip>100070</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>April 25, 2020</study_first_submitted>
  <study_first_submitted_qc>April 25, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 28, 2020</study_first_posted>
  <last_update_submitted>April 25, 2020</last_update_submitted>
  <last_update_submitted_qc>April 25, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Beijing Tiantan Hospital</investigator_affiliation>
    <investigator_full_name>Yuming Peng</investigator_full_name>
    <investigator_title>Associate professor</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

